ABQCOWBOY;4800944 said:
http://www.tdfblog.com/2005/08/lequipe_story_a.html
So the story linked above is getting a lot of play this morning, and a lot of the headlines I'm seeing totally miss the point. "Armstrong tested positive in 1999," screams one.
Well, no. There was no test for EPO until 2001, and Tour riders weren't specifically screened for it until 2004. What L'Equipe has done is built what they claim is a paper trail, linking Armstrong's "B" samples, collected in 1999, with samples that were provided to the World Anti-Doping Agency for use in developing the EPO test.
The blood urine samples in question were allegedly anonymous, with only a numerical identifier, but L'Equipe claims to have copies of Armstrong's medical certificates, signed by both race doctors and the rider after doping tests, that show the same numerical identifier as the WADA samples.
Armstrong is unlikely to be sanctioned, since there's no corroborating sample available, and since the French national lab provided them to WADA “on condition that they could not be used in any disciplinary proceeding.
Just a nit, but the samples in question seem to have been urine rather than blood. I am also puzzled as to why some reports suggest there is enough remaining of the B sample to allow further testing, whereas Armstrong's statement ("I have no way to defend myself") and other articles suggest that there is nothing left of the B sample. I hope Armstrong continues to press the British libel prosecution and the lawsuit against the insurance company denying the $5MM Tour victory bonus, since this will clearly become an issue in those cases. If Armstrong is clean, the lawsuits will provide a forum for him to prove it (either by retesting the sample or by refuting the science).
________________________
Cycling didn't even have an organization that monitored PEDs until after 1999. PEDs were not even illegal in 1999.
ROFL. Armstrong tested positive which laughs at the major cry he had made at every turn. And the same lame one you are making now.
He flat out failed multiple tests. He had tests overturned, had tests that weren't considered illegal "at the time" but he tested positive for the drugs in question. He had doctor's excuses provided after the fact for other positive tests.
If you want to continue to insult your own intelligence with this lazy and inaccurate line of reasoning feel free. Not even Lance is bothering with that defense anymore. There are tons of evidence including financial trails for paid off testing officials and doping doctors.
There is email and text evidence sent from Lance's account admitting he doped.
http://usatoday30.usatoday.com/spor...terprise docs/armstrong-reasoned-decision.pdf
B. 1999 Tour de France Samples
In 2004, the French Anti-Doping Laboratory (LNDD) decided, on its own initiative, to
start a research project on stored urine samples from the 1999 Tour de France in order to
evaluate, among other things, the use of EPO during the 1999 Tour, as a valid test for EPO had
not been available until 2000. At the time it conducted this research project, LNDD did not have
any way to know or determine the source of any urine samples it tested. The results of this
research were sent to WADA by LNDD in August 2005.
On August 23, 2005, L’Equipe published an article headlined, “The Armstrong Lie.” The
article published six doping control forms pertaining to Armstrong’s urine samples from the
1999 Tour, and a summary of findings from LNDD concerning its research on these samples.
The newspaper reported that, on six occasions during the 1999 Tour, Armstrong’s samples
showed the presence of EPO. L’Equipe had been able to connect these samples to Armstrong by
obtaining Armstrong’s 1999 doping control forms from UCI with Armstrong’s consent.
Following this publication linking Armstrong to samples containing EPO, WADA asked
UCI to look into the matter. In October 2005, in response to calls by the IOC and WADA for an
independent investigation, the UCI appointed Dutch lawyer Emile Vrijman to investigate
LNDD’s handling of the urine samples. In May 2006, Vrijman published his report, concluding
LNDD had not followed proper anti-doping protocol (e.g., failing to confirm a positive A
Sample with analysis of a B Sample) in its testing of the samples and therefore the samples could
not constitute proof of anti-doping rule violations by Armstrong.
In the course of the investigation, LNDD confirmed to WADA that the samples in
question had been stored in a controlled access zone of the laboratory at -20ºC the entire time
and there was no scientific basis to believe the samples could have undergone any process of
Page | 143
deterioration that would explain the presence of EPO other than it was present in the samples
when originally provided in 1999. As WADA pointed out in its official response to Vrijman’s
report, his report inappropriately focused solely on whether LNDD had followed established
protocol applicable to the analysis of samples for the purpose of making “adverse analytical
findings.”798 As the Code makes clear, however, analytical information which does not
otherwise satisfy all requirements to establish “Presence” of a prohibited substance under Article
2.1 may nevertheless constitute “reliable means” to corroborate other evidence establishing an
anti-doping rule violation.799
Even accepting that LNDD’s analysis of Armstrong’s 1999 samples would not have met
the requirements for establishing the “Presence” of a prohibited substance under Article 2.1 of
the Code, this does not take away from the fact that LNDD’s findings may be used to corroborate
other evidence to support a finding of “Use” of a prohibited substance or other anti-doping rule
violation.
USADA recently obtained the chart of LNDD’s testing results relating to the 1999
samples. This information was provided to USADA by the French Anti-Doping Agency in
accordance with its authority under the French Code of Sport. The chart shows the results for all
of the 1999 Tour de France samples tested for EPO by LNDD in 2004 and 2005, including the
six samples subsequently identified in the L’Equipe article as Armstrong’s. According to the
chart, each of Armstrong’s six samples from the 1999 Tour de France tested positive for the
presence of EPO on each of three positivity criteria, including the current EPO positivity criteria.